PGD Cancun (Pre-implantation Genetic Diagnosis) is an advanced fertility treatment being used in our prominent IVF clinic in Cancun to diagnosis abnormalities in embryos. At AFCC, genetic testing and advanced assisted reproduction have united to introduce a powerful technology for intended parents to choose which embryos to implant based on genetic testing outcomes.
IVF Cancun implements a progressive setting for PGD — both by technical modernization and clinical success rates, to aid a wide variety of intended parents to have healthy pregnancies. This procedure consists on taking one cell of the embryo to later perform a genetic diagnosis through FISH or PCR procedure.
With this procedure, we can dismiss 95% of all chromosomal diseases which can affect humans. This techniques of molecular biology are of far more complexity and are designated for aged women with good follicular dotes and/or in couples which may be carrying some preventable genetic mutation. The PCR is elaborated before the embryo transfer and can help us to avoid the transmission of inherited diseases to our children.
Good Candidate for PGD Cancun
PGD testing may be appropriate for couples with:
- Advanced maternal age (>36)
- Experience of repeated miscarriage
- Experienced repeated IVF failure
- Previously pregnancy with a chromosomal abnormality
- Risk of passing a genetic disorder on to their children
- Risk of having children with a particular X-linked disorder
- A partner who carries a balanced chromosomal translocation
PGD with embryos.
Patients who are at risk for producing embryos with specific genetic abnormalities can find comfort with our PGD Cancun procedure. PGD involves embryo biopsy including the removal of a single cell from an embryo on Day 3 of growth. The embryo biopsy is executed by our IVF Cancun embryologists. Results are available within 24 hours; the embryos that are determined to be chromosomally and or genetically normal are then transferred on Day 4.
PGD Cancun is also successfully implicated for gender selection Cancun purposes.
PGD with eggs.
Same as the PGD Cancun with embryos, this technique helps us detect maternal genetic or chromosomal inherited diseases through a biopsy of the ovule before the embryo is formed.
Genetic Analysis with PGD
Chromosomal Aneuploidy —
Chromosomal aneuploidy refers to an abnormality of chromosome number within the cells of the embryos. Chromosomal irregularities may involve errors that occurred during cell division. Aneuploidy testing screens for common irregularities involving chromosomes X, Y, 13, 15, 16, 18, 21 and 22. This testing may be right for couples with advanced maternal age, couples with repeated miscarriages, couples experiencing repeated IVF failure, and couples who have previously had a pregnancy with a chromosomal abnormality.
Chromosomal Translocations —
Chromosomal translocations encompass redisposition of the chromosomal material. Individuals who are carriers of a translocation may experience trouble with reproduction because they are producing chromosomally unbalanced embryos. The translocation may be the cause of an exertion conceiving, or may result in miscarriage after conception.
Single Gene Disorders —
Single gene disorders are genetic inheritable circumstances caused by the alteration or mutation of a specific gene located on one of the chromosomes. Individuals who are affected by one of these disorders, or who have a family history of a genetic disorder, may be at risk for passing the condition onto their children. Single gene disorders include cystic fibrosis, sickle cell anemia, Tay Sachs disease, and Fragile X syndrome.